Penumbra (PEN) EBT Margin Growth (1y) (2015 - 2026)
Penumbra (PEN) EBT Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 165.00 |
| 10 | Penumbra | 12.79 Bn | 12.13 Bn | 264.94 Mn | -151.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -151.00 |
| Mar 31, 2026 | -241.00 |
| Dec 31, 2025 | 246.00 |
| Sep 30, 2025 | 154.00 |
| Jun 30, 2025 | 3,936.00 |
| Mar 31, 2025 | 828.00 |
| Dec 31, 2024 | 65.00 |
| Sep 30, 2024 | 830.00 |
| Jun 30, 2024 | -3,348.00 |
| Mar 31, 2024 | 166.00 |
| Dec 31, 2023 | 1,018.00 |
| Sep 30, 2023 | 349.00 |
| Jun 30, 2023 | 803.00 |
| Mar 31, 2023 | 609.00 |
| Dec 31, 2022 | 2,330.00 |
| Sep 30, 2022 | -267.00 |
| Jun 30, 2022 | -610.00 |
| Mar 31, 2022 | -987.00 |
| Dec 31, 2021 | -1,977.00 |
| Sep 30, 2021 | 1,715.00 |